Int. J. Mol. Sci. 2014, 15(3), 5163-5174; doi:10.3390/ijms15035163
Article

Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle

* email and email
Received: 27 October 2013; in revised form: 24 February 2014 / Accepted: 10 March 2014 / Published: 24 March 2014
(This article belongs to the collection Molecular Mechanisms of Human Liver Diseases)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Many investigations have revealed that a low recurrence rate of hepatocellular carcinoma (HCC) is associated with high serum albumin levels in patients; therefore, high levels of serum albumin are a major indicator of a favorable prognosis. However, the mechanism inhibiting the proliferation of HCC has not yet been elucidated, so we investigated the effect of serum albumin on HCC cell proliferation. Hep3B was cultured in MEM with no serum or containing 5 g/dL human albumin. As control samples, Prionex was added to generate the same osmotic pressure as albumin. After 24-h incubation, the expressions of α-fetoprotein (AFP), p53, p21, and p57 were evaluated with real-time PCR using total RNA extracted from the liver. Protein expressions and the phosphorylation of Rb (retinoblastoma) were determined by Western blot analysis using total protein extracted from the liver. For flow cytometric analysis of the cell cycle, FACS analysis was performed. The percentages of cell cycle distribution were evaluated by PI staining, and all samples were analyzed employing FACScalibur (BD) with appropriate software (ModFit LT; BD). The cell proliferation assay was performed by counting cells with using a Scepter handy automated cell counter (Millipore). The mRNA levels of AFP relative to Alb(−): Alb(−), Alb(+), and Prionex, were 1, 0.7 ± 0.2 (p < 0.001 for Alb(−)), and 1 ± 0.3, respectively. The mRNA levels of p21 were 1, 1.58 ± 0.4 (p = 0.007 for Alb(−) and p = 0.004 for Prionex), and 0.8 ± 0.2, respectively. The mRNA levels of p57 were 1, 4.4 ± 1.4 (p = 0.002 for Alb(−) and Prionex), and 1.0 ± 0.1, respectively. The protein expression levels of Rb were similar in all culture media. The phosphorylation of P807/811 and P780 of Rb protein was reduced in Alb(+). More cells in the G0/G1 phase and fewer cells in S and G2/M phases were obtained in Alb(+) than in Alb(−) (G0/G1: 60.9%, 67.7%, 61.5%; G2/M: 16.5%, 13.1%, 15.6%; S: 22.6%, 19.2%, 23.0%, Alb(−), Alb(+), Prionex, respectively). The same results were obtained in HepG2. Cell proliferation was inhibited in 5 g/dL albumin medium in both HepG2 cells and Hep3B cells in 24 h culture by counting cell numbers. The presence of albumin in serum reduces the phosphorylation of Rb proteins and enhances the expression of p21 and p57, following an increase in the G0/G1 cell population, and suppresses cell proliferation. These results suggest that albumin itself suppresses the proliferation of hepatocellular carcinoma.
Keywords: albumin; hepatocellular carcinoma; cell cycle
PDF Full-text Download PDF Full-Text [843 KB, uploaded 19 June 2014 05:33 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Nojiri, S.; Joh, T. Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle. Int. J. Mol. Sci. 2014, 15, 5163-5174.

AMA Style

Nojiri S, Joh T. Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle. International Journal of Molecular Sciences. 2014; 15(3):5163-5174.

Chicago/Turabian Style

Nojiri, Shunsuke; Joh, Takashi. 2014. "Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle." Int. J. Mol. Sci. 15, no. 3: 5163-5174.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert